SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-014884
Filing Date
2019-01-23
Accepted
2019-01-23 17:09:33
Documents
6
Period of Report
2019-01-23
Items
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d627493d8k.htm 8-K 21384
2 EX-99.1 d627493dex991.htm EX-99.1 8199
3 EX-99.2 d627493dex992.htm EX-99.2 57250
4 EX-99.3 d627493dex993.htm EX-99.3 82859
5 GRAPHIC g627493g0123173325142.jpg GRAPHIC 5080
6 GRAPHIC g627493g19h60.jpg GRAPHIC 126914
  Complete submission text file 0001193125-19-014884.txt   353187
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

IRS No.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 19538035
SIC: 2834 Pharmaceutical Preparations